CPED1

There are 3 papers on CPED1 in aging research: 1 observational study in people, 1 review.

3 papers study it1 finding

HGNC NCBI Gene Taxon

1 new paper in 30 daysSee all 3 papers on CPED1

Humans1
In silico1

Associations

1

Sarcopenia

upin silico1OR 1.0292

1 study

CPED1 raises the risk of sarcopenia in silico (OR = 1.0292, 95% CI = 1.0089-1.0500, p = 0.0047).
“CPED1 (OR = 1.0292, 95% CI = 1.0089-1.0500, p = 0.0047) and FNBP4 (OR = 1.1096, 95% CI = 1.0316-1.1934, p = 0.0051) were associated with an increased risk of sarcopenia.”
In silico
Combined single-cell RNA sequencing and mendelian randomization to identify biomarkers associated with circadian rhythm in sarcopenia
Mammalian genome : official journal of the International Mammalian Genome SocietyMay 11, 2026

More on Sarcopenia

Latest

2 papers in 12 months

AHA Scientific Sessions 2026 AbstractNov 7

Mitral Annulus-to-Leaflet Area: A Novel Quantitative Endophenotype for Mitral Valve Prolapse Enables Risk Stratification and Genetic Discovery

Cohort study of 418,420 peopleBiomarkers

Mammalian GenomeMay 12

Combined single-cell RNA sequencing and mendelian randomization to identify biomarkers associated with circadian rhythm in sarcopenia

Computational studySarcopenia

Geriatrics & Gerontology InternationalMar 29

Implementation of personalized medicine for fracture risk assessment in osteoporosis

ReviewFemoral fractures